For the twelve months ended Sep 30, 2026, Research Frontiers Incorporated reported $371.8K of revenue and -$2.46M of net income.
REFR revenueQ3 2026$77.0K
- Quarter YoY
- -78.6%
- QoQ
- -10.8%
- FY YoY
- -16.0%
- 5Y CAGR
- +6.2%
- 10Y CAGR
- -5.7%
REFR revenue was $77.0K in fiscal Q3 2026 (ended Sep 30, 2026), down 78.6% from a year earlier and down 10.8% from the prior quarter. For the full fiscal 2025 it was $1.12M, down 16.0% from fiscal 2024. Compound annual growth was +6.2% over 5 years and -5.7% over 10 years. It rose in 5 of the last 10 fiscal years.
REFR net incomeQ3 2026-$510.3K
REFR net income was -$510.3K in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$298.5K a year earlier. For the full fiscal 2025 it was -$2.05M, compared with -$1.31M in fiscal 2024.
REFR EPSQ3 2026-$0.01
REFR diluted EPS was -$0.01 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.01 a year earlier. For the full fiscal 2025 it was -$0.06, compared with -$0.04 in fiscal 2024.
REFR free cash flowQ3 2026-$443.3K
REFR free cash flow was -$443.3K in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$143.9K a year earlier. For the full fiscal 2025 it was -$1.33M, compared with -$790.4K in fiscal 2024.
Source: XBRL data Research Frontiers Incorporated files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.